About

Laurent-Dominique Piveteau joined Debiotech in 2005 and was appointed as Chief Executive Officer in 2015. Prior to this, Dr Piveteau held several positions in R&D and in business development. He developed a coating for bone implants in collaboration with the Robert Mathys Foundation, he was a researcher at MIT (Cambridge, MA, US) working on contrast media for MRI, and worked in technology transfer at the Swiss Federal Institute of Technology in Lausanne (EPFL) (Switzerland). In parallel to his current position, Dr Piveteau also teaches Innovation Economics at EPFL. He holds an MSc in Physics from the ETH Zürich (Switzerland), a PhD from the University of Fribourg (Switzerland) and an MBA from INSEAD in Singapore and Fontainebleau (France).

Contributions

PREFILLED SYRINGES

LOW-COST DISPOSABLE WEARABLE INJECTOR PLATFORM FOR LARGE VOLUMES OF VISCOUS DRUGS

Eric Chappel, Dimitry Dumont-Fillon and Laurent-Dominique Piveteau discuss Debiotech’s novel wearable injector technology, which utilises a propellant vapour system to drive the injection, making the device both space- and cost-efficient.

More contributions

MICRONEEDLES

YOUR SOLUTION FOR SUCCESSFUL INTRADERMAL DELIVERY

Paul Vescovo and Laurent-Dominique Piveteau discuss the design of the Debioject™ microneedle device and inserter, and its applications, particularly in intradermal delivery of vaccines.